Bellane-Chantelot et al listed criteria for recognizing a patient with maturity-onset diabetes of the young associated with anomalies of HNF1A (MODY3). These can help to differentiate MODY 3 from early-onset diabetes 2. The authors are from multiple hospitals in France.
